Upon Dexo vaccination, poly(I:C) molecules could participate in the induction of immune cell activation and tumor growth arrest by direct engagement of TLR-3 molecules expressed by myeloid DCs and T cells and by tumor cells, respectively, even though exposure to nucleases may lead to their rapid degradation in vivo42, 43. This evidence concerns the gene TLR3 and neoplasm.